- Home
- IMAB vs EVC Comparison
IMAB vs EVC Comparison
Compare IMAB & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- EVC
- Stock Information
- Founded
- IMAB 2014
- EVC 1996
- Country
- IMAB United States
- EVC United States
- Employees
- IMAB N/A
- EVC N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- EVC Broadcasting
- Sector
- IMAB Health Care
- EVC Industrials
- Exchange
- IMAB Nasdaq
- EVC Nasdaq
- Market Cap
- IMAB 200.9M
- EVC 188.3M
- IPO Year
- IMAB 2020
- EVC 2000
- Fundamental
- Price
- IMAB $2.11
- EVC $2.39
- Analyst Decision
- IMAB Strong Buy
- EVC
- Analyst Count
- IMAB 3
- EVC 0
- Target Price
- IMAB $6.33
- EVC N/A
- AVG Volume (30 Days)
- IMAB 392.1K
- EVC 244.6K
- Earning Date
- IMAB 05-15-2025
- EVC 08-05-2025
- Dividend Yield
- IMAB N/A
- EVC 8.37%
- EPS Growth
- IMAB N/A
- EVC N/A
- EPS
- IMAB N/A
- EVC N/A
- Revenue
- IMAB N/A
- EVC $378,623,000.00
- Revenue This Year
- IMAB N/A
- EVC $64.06
- Revenue Next Year
- IMAB N/A
- EVC N/A
- P/E Ratio
- IMAB N/A
- EVC N/A
- Revenue Growth
- IMAB N/A
- EVC 23.10
- 52 Week Low
- IMAB $0.60
- EVC $1.58
- 52 Week High
- IMAB $3.08
- EVC $2.73
- Technical
- Relative Strength Index (RSI)
- IMAB 49.47
- EVC 51.93
- Support Level
- IMAB $2.01
- EVC $2.27
- Resistance Level
- IMAB $2.25
- EVC $2.46
- Average True Range (ATR)
- IMAB 0.13
- EVC 0.10
- MACD
- IMAB -0.03
- EVC -0.02
- Stochastic Oscillator
- IMAB 25.00
- EVC 34.85
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.